Our Pricing

Best Weight Loss Injections UK Reviews - In Stock Now at Cured Pharmacy

Published on: June 03, 2026

Finding the best weight loss injections UK reviews can be overwhelming when comparing Mounjaro, Wegovy, and Saxenda. At Cured Pharmacy, our UK-registered clinical team has supported thousands of patients through their weight management journey, and we've compiled this evidence-based guide to help you understand which prescription injectable treatment may be right for you, all available with transparent upfront pricing and same-day prescriber approval.

How GLP-1 Weight Loss Injections Work: The Science Behind the Results

GLP-1 receptor agonists represent the most significant advancement in obesity pharmacotherapy in decades. These medications mimic glucagon-like peptide-1, a naturally occurring hormone that regulates appetite, gastric emptying, and glucose metabolism [1]. When administered as a weekly injection, they bind to GLP-1 receptors in the brain's hypothalamus, reducing hunger signals and increasing satiety after smaller meals.

Mounjaro (tirzepatide) goes one step further as the UK's first dual GIP/GLP-1 receptor agonist, activating both glucose-dependent insulinotropic polypeptide and GLP-1 pathways simultaneously [2]. This dual mechanism explains why clinical trial participants achieved average weight reductions of 22.5% over 72 weeks in the SURPASS-3 study — the highest efficacy demonstrated in any obesity medication trial to date [2].

Wegovy (semaglutide) operates through the single GLP-1 pathway but at a higher dose than its diabetes formulation. In the STEP-1 trial, participants lost an average of 14.9% of their body weight over 68 weeks when combined with lifestyle intervention [3]. Saxenda (liraglutide), an earlier-generation daily injection, demonstrated average weight loss of 8% over 56 weeks in the SCALE trial [4].

Mounjaro Weight Loss Injections: Comprehensive UK Review

Mounjaro has rapidly become the most requested weight loss injection at Cured Pharmacy since receiving MHRA approval for weight management in the UK. The medication is available as a pre-filled KwikPen in escalating doses from 2.5mg to 15mg, allowing your prescriber to titrate gradually and minimise gastrointestinal side effects.

What sets Mounjaro apart in our clinical experience is the consistency of results. Across our patient base, we've observed that individuals who adhere to the prescribed regimen and maintain recommended lifestyle modifications typically begin noticing appetite reduction within the first week, with measurable weight loss evident by week four. The dual receptor mechanism appears to produce more sustained satiety compared to single-pathway alternatives.

The most common side effects reported by our patients include mild nausea during dose escalation, occasional constipation, and temporary injection site reactions [2]. These typically resolve within 2-3 weeks as your body adapts. Our superintendent pharmacist Tarun Kumar recommends starting injections on the same day each week, preferably when you can rest if needed during the initial adjustment period.

Who Is Mounjaro Suitable For?

Mounjaro is licensed in the UK for adults with a BMI of 30 kg/m² or above, or 27 kg/m² with at least one weight-related comorbidity such as hypertension, type 2 diabetes, or obstructive sleep apnoea [2]. Your UK prescriber will assess your full medical history, current medications, and weight loss goals during your free online consultation. The treatment is not suitable during pregnancy, for individuals with a personal or family history of medullary thyroid carcinoma, or those with multiple endocrine neoplasia syndrome type 2.

Wegovy (Semaglutide) Review: Proven Efficacy at Competitive UK Pricing

Wegovy has established itself as a gold-standard weight loss injection since its UK launch, backed by the most extensive clinical trial programme in obesity medicine history. The STEP trials enrolled over 4,500 participants across multiple studies, consistently demonstrating significant weight reduction when combined with reduced-calorie diet and increased physical activity [3].

At Cured Pharmacy, Wegovy remains our most prescribed weight loss injection due to its established safety profile and reliable stock availability. The treatment uses a once-weekly injection pen with a simple click mechanism, starting at 0.25mg and gradually increasing to a maintenance dose of 2.4mg over 16-20 weeks. This gradual titration schedule helps your body adapt to the medication whilst minimising common side effects like nausea and diarrhoea.

Our clinical team has observed that patients who maintain consistent injection timing and follow the dose escalation schedule as prescribed achieve the best outcomes. The medication works by slowing gastric emptying and reducing appetite through central nervous system pathways, making it easier to adhere to a reduced-calorie eating plan without experiencing intense hunger [3].

Wegovy Side Effects and Management Strategies

The most frequently reported side effects in our patient population include nausea (affecting approximately 44% of users initially), diarrhoea, constipation, and abdominal discomfort [3]. These gastrointestinal symptoms typically peak during dose escalation and diminish significantly once you reach your maintenance dose. We advise patients to eat smaller, more frequent meals, avoid high-fat foods during the adjustment period, and stay well-hydrated. If side effects become troublesome, your prescriber can slow the titration schedule or temporarily maintain your current dose before progressing.

Saxenda (Liraglutide) Review: Daily Injection Option for Gradual Weight Loss

Saxenda offers a different approach as a daily injection, which some patients prefer for more consistent appetite control throughout the week. The medication uses the same active ingredient (liraglutide) as the diabetes treatment Victoza, but at a higher dose specifically licensed for weight management by the MHRA.

In the SCALE Obesity and Prediabetes trial, 63.2% of participants achieved at least 5% weight loss over 56 weeks, with 33.1% losing 10% or more of their starting body weight [4]. Whilst these results are more modest compared to newer dual-agonist treatments, Saxenda remains an excellent option for patients who prefer daily dosing or have contraindications to higher-potency alternatives.

The daily injection schedule requires more commitment but provides flexibility in timing — you can administer Saxenda at any time of day, with or without food, as long as you maintain consistency. Our patients report that the daily ritual helps reinforce their commitment to lifestyle changes and provides a tangible daily reminder of their weight loss goals.

Comparing Best Weight Loss Injections UK: Mounjaro vs Wegovy vs Saxenda

When our clinical team assesses which injection is most appropriate, we consider multiple factors beyond just efficacy data. Mounjaro typically produces the highest average weight loss but requires weekly injections and has the highest starting price point. Wegovy offers an excellent balance of proven efficacy and competitive pricing, with extensive real-world safety data from millions of patient-years of exposure globally.

Saxenda's daily dosing appeals to patients who want more control over their regimen or who experience side effects with weekly injections. The lower per-dose concentration means side effects can be managed more precisely by adjusting daily doses, rather than waiting a full week between injections. Additionally, some patients find that daily injections provide more consistent appetite suppression throughout the week.

Your choice should be guided by your prescriber's clinical assessment, your lifestyle preferences, budget considerations, and how you respond to the initial trial period. At Cured Pharmacy, we offer transparent upfront pricing before your consultation, so you can make an informed decision without hidden costs or surprise fees after prescriber approval.

Making Your Decision: Factors to Consider

Beyond clinical efficacy, consider practical factors like injection frequency (daily vs weekly), your tolerance for potential side effects during titration, and long-term affordability. All three medications require ongoing treatment to maintain weight loss — discontinuation typically results in weight regain over subsequent months [1][3][4]. Your UK prescriber will discuss realistic expectations, including the importance of concurrent lifestyle modifications and the likelihood of needing extended treatment duration for sustained results.

Stock Availability and How to Order Weight Loss Injections at Cured Pharmacy

Supply chain challenges have affected weight loss injection availability across UK pharmacies throughout 2024, but Cured Pharmacy maintains active stock monitoring and transparent availability updates. We currently have Mounjaro, Wegovy, and Saxenda in stock, with real-time inventory reflected on each product page before you begin your consultation.

Our ordering process is designed for convenience and discretion. Complete our free online medical questionnaire (typically under 3 minutes), which is reviewed by a UK-registered prescriber within hours during business days. If approved, your prescription is sent directly to our GPhC-registered pharmacy, and your medication is dispatched in completely discreet packaging via tracked courier, usually arriving within 1-2 working days.

As a UK-registered pharmacy (GPhC 9012511) under the supervision of superintendent pharmacist Tarun Kumar (GPhC 2233073), we only supply genuine UK-licensed medications. Every pen, cartridge, and needle is sourced through legitimate UK pharmaceutical wholesalers and stored in our temperature-controlled facilities to maintain efficacy. You'll never receive grey-market imports or compounded alternatives when you order from Cured Pharmacy.

Prescription Requirements and Clinical Assessment

All weight loss injections are prescription-only medicines in the UK and cannot legally be supplied without a valid prescription from a UK-registered prescriber. Our clinical assessment evaluates your BMI, weight loss history, current medications, relevant medical conditions, and suitability for GLP-1 therapy. The prescriber may request additional information or suggest alternative treatments if injectable medications are not appropriate for your circumstances. This safeguarding process ensures your safety and compliance with MHRA regulations and General Pharmaceutical Council standards.

Scientific References

1. Drucker, D. J. (2022). GLP-1 physiology informs the pharmacotherapy of obesity. Molecular Metabolism, 57, 101351. https://doi.org/10.1016/j.molmet.2021.101351 [accessed 13 August 2026]
2. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
3. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
4. Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Weight loss results vary between individuals and depend on adherence to prescribed treatment and lifestyle modifications.